Health

Cagent Vascular Raises $30 Million Series C Financing

Funds will be used to accelerate US market adoption and to expand the product portfolio of the first and only Serration Angioplasty Technology Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M. U.S. Venture Partners (USVP), led the round. Participation included new […]

The post Cagent Vascular Raises $30 Million Series C Financing appeared first on Ben Franklin Technology Partners.

... Read More >


Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma

Vittoria Biotherapeutics has announced the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA). For the initiation of a first-in-human Phase 1 clinical trial to evaluate the Company’s lead candidate, VIPER-101, a gene-edited, autologous, CAR-T cell therapy for treatment of patients with relapsed or refractory T-cell lymphoma. “The […]

The post Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma appeared first on Ben Franklin Technology Partners.

... Read More >


SAIL Fusion Announces First Implantations Of Its BowTie™ Sacroiliac Fusion System

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon AO principles, today announced that it has conducted the first implantations of its novel BowTie SI Fusion System. The surgeries began on October 14th and were conducted by Dr. Peter Whang, Associate Professor of Orthopaedics […]

The post SAIL Fusion Announces First Implantations Of Its BowTie™ Sacroiliac Fusion System appeared first on Ben Franklin Technology Partners.

... Read More >


Astarte Medical And Tiny Health Join Forces To Optimize Gut Health For Vulnerable Preterm Infants

The new partnership will seek to develop an end-to-end NICU solution to stratify and treat at-risk babies. Astarte Medical, a leading pediatric clinical intelligence company, is forming a joint venture with Tiny Health, makers of gut microbiome tests for babies and expecting parents. The partners have agreed to develop a clinical-facing technology solution to support gut […]

The post Astarte Medical And Tiny Health Join Forces To Optimize Gut Health For Vulnerable Preterm Infants appeared first on Ben Franklin Technology Partners.

... Read More >


Nobias Therapeutics Announces Acceptance Of Late-Breaking Abstract

Nobias Therapeutics, a biotechnology company pioneering AI-based deep phenotyping techniques to discover advanced therapeutics, today announced new results. From a Phase 2 clinical trial of NB-001 (fasoracetam) for the treatment of the neuropsychiatric symptoms associated with 22q11.2 deletion syndrome (“22q11DS”) in children have been selected for a poster presentation at the 52nd Child Neurology Society […]

The post Nobias Therapeutics Announces Acceptance Of Late-Breaking Abstract appeared first on Ben Franklin Technology Partners.

... Read More >


Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy

Advent Therapeutics, Inc., a biotechnology company pioneering an optimized retinol palmitate (vitamin A) drug product as a breakthrough non-invasive inhaled neonatal lung therapy, has been awarded a $3 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase IIB grant. This grant allows the Company to position its novel aerosolized vitamin A formulation […]

The post Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy appeared first on Ben Franklin Technology Partners.

... Read More >


Cagent Vascular Announces Initial RECOIL Study Results: Serranator Demonstrates 49% Less Recoil Than POBA In BTK Arteries

Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee (BTK) RECOIL study. This Core Lab-Adjudicated Recoil analysis, the first of its kind, evaluated vessel recoil in lesions treated with Serranator® verses Plain Old Balloon Angioplasty (POBA). The study results demonstrated that lesions treated using […]

The post Cagent Vascular Announces Initial RECOIL Study Results: Serranator Demonstrates 49% Less Recoil Than POBA In BTK Arteries appeared first on Ben Franklin Technology Partners.

... Read More >


VESTECK Continues To Help Patients Around The World

VESTECK, Inc. is excited to announce the successful completion of 7 Endovascular Aortic Repair (EVAR) clinical cases with the “SUTURE-TIGHT”™ device. Professor Dainis Krievins and Dr. Bao Bui, performed the 2 most recent EVAR procedures in Riga, Latvia, suturing EVAR grafts to the aorta with the “SUTURE-TIGHT”™ catheter. This brings VESTECK, Inc. to a total of 7 clinical cases […]

The post VESTECK Continues To Help Patients Around The World appeared first on Ben Franklin Technology Partners.

... Read More >


First All-Metal Patient-Specific Instrument In Ankle Arthroplasty

Axiom PSR is made of titanium alloy, which means it will have better durability compared to implants made from ceramic or polyethene. Restor3d has received approval from the Food and Drug Administration (FDA) for the first all-metal patient-specific instrument (PSI) in ankle arthroplasty. This product, named Axiom PSR, will be added to Kinos Medical’s total […]

The post First All-Metal Patient-Specific Instrument In Ankle Arthroplasty appeared first on Ben Franklin Technology Partners.

... Read More >


Across Q1 And Q2, Ben Franklin Tech Partners Is Investing Nearly $3M Into 12 Philly-Area Startups

Plus, the state-backed investment firm is raising a $25 million fund, similar to the Go Philly Fund from 2019 in partnership with Newtown-headquartered EPAM. It’s a busy start to the year for Ben Franklin Technology Partners‘ (BFTP) Southeastern Pennsylvania branch. The state-backed firm recently announced it’s slated to make investments in seven local startup companies. The […]

The post Across Q1 And Q2, Ben Franklin Tech Partners Is Investing Nearly $3M Into 12 Philly-Area Startups appeared first on Ben Franklin Technology Partners.

... Read More >